Published in Pediatr Infect Dis J on September 01, 1998
Helicobacter pylori infection. World J Gastroenterol (2000) 1.54
Gastroenterology in developing countries: issues and advances. World J Gastroenterol (2009) 1.53
Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2011) 1.41
Transient and persistent Helicobacter pylori colonization in Native American children. J Clin Microbiol (2003) 1.14
Helicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveys. Dig Dis Sci (2006) 1.09
Longitudinal analysis of serological responses of adults to Helicobacter pylori antigens. J Infect Dis (2010) 0.80
The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med (1994) 4.41
Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study. Br Med J (Clin Res Ed) (1984) 3.62
Stability of related human and chicken Campylobacter jejuni genotypes after passage through chick intestine studied by pulsed-field gel electrophoresis. Appl Environ Microbiol (1999) 2.38
No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet (1998) 2.01
Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. J Bacteriol (1992) 1.98
The polypeptide tunnel system in the ribosome and its gating in erythromycin resistance mutants of L4 and L22. Mol Cell (2001) 1.94
Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother (1992) 1.92
Human rabies of bat origin in Europe. Lancet (1986) 1.85
A three-year study of Campylobacter jejuni genotypes in humans with domestically acquired infections and in chicken samples from the Helsinki area. J Clin Microbiol (2000) 1.81
Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol (1992) 1.76
Detection and typing of Campylobacter jejuni and Campylobacter coli and analysis of indicator organisms in three waterborne outbreaks in Finland. Appl Environ Microbiol (2003) 1.75
Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland. Antimicrob Agents Chemother (1991) 1.72
Low biological activity of Helicobacter pylori lipopolysaccharide. Infect Immun (1992) 1.71
Bile duct injuries during laparoscopic cholecystectomy: a 1994-2001 audit on 13,718 operations in the area of Rome. Surg Endosc (2003) 1.68
The importance of aortic arch or subclavian angiography before coronary reconstruction. Chest (1974) 1.68
An acid extract as a common antigen in Campylobacter coli and Campylobacter jejuni strains. J Clin Microbiol (1983) 1.65
Serology of Campylobacter fetus ss. jejuni )"related" campylobacters). Demonstration of strain-specific and interstrain-related antigens by immunoelectrophoresis and co-agglutination. Acta Pathol Microbiol Scand B (1980) 1.64
Helicobacter pylori induces lymphocyte activation in peripheral blood cultures. Clin Exp Immunol (1990) 1.62
Typing of human Campylobacter jejuni isolates in Finland by pulsed-field gel electrophoresis. J Clin Microbiol (1998) 1.59
Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J (2000) 1.56
Characterization of ATP and DNA binding activities of TrwB, the coupling protein essential in plasmid R388 conjugation. J Biol Chem (1999) 1.50
Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect (1997) 1.49
US of nerve entrapments in osteofibrous tunnels of the upper and lower limbs. Radiographics (2000) 1.49
The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect (2004) 1.49
Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N-acetylneuraminic acid and 2,3-diamino-2,3-dideoxy-D-glucose. J Bacteriol (1991) 1.46
Topology of the components of the DNA packaging machinery in the phage phi29 prohead. J Mol Biol (2000) 1.45
Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin Infect Dis (2006) 1.44
Evidence that cagA(+) Helicobacter pylori strains are disappearing more rapidly than cagA(-) strains. Gut (2002) 1.43
Prolonged campylobacter gastroenteritis in a patient with hypogammaglobulinaemia. Acta Med Scand (1983) 1.41
Campylobacter enteritis in 188 hospitalized patients. Arch Intern Med (1983) 1.41
Campylobacter-triggered reactive arthritis: a population-based study. Rheumatology (Oxford) (2002) 1.38
A novel neural network technique for analysis and classification of EM single-particle images. J Struct Biol (2001) 1.37
Prognosis of cryptogenic fibrosing alveolitis. Thorax (1983) 1.34
Mumps and rubella eliminated from Finland. JAMA (2000) 1.32
Serology of Campylobacter fetus ss. jejuni. 2 Serotyping of live bacteria by slide, latex and co-agglutination tests. Acta Pathol Microbiol Immunol Scand B (1982) 1.30
Reactive arthritis after campylobacter jejuni enteritis in patients with HLA-B27. Lancet (1980) 1.29
Arthritis associated with Campylobacter jejuni enteritis. Scand J Rheumatol (1981) 1.27
Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study. Aliment Pharmacol Ther (2005) 1.25
Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro. Arthritis Rheum (1980) 1.21
Decreasing trend of overlapping multilocus sequence types between human and chicken Campylobacter jejuni isolates over a decade in Finland. Appl Environ Microbiol (2010) 1.21
Genomic relatedness within five common Finnish Campylobacter jejuni pulsed-field gel electrophoresis genotypes studied by amplified fragment length polymorphism analysis, ribotyping, and serotyping. Appl Environ Microbiol (2001) 1.20
Etiology of measles- and rubella-like illnesses in measles, mumps, and rubella-vaccinated children. J Infect Dis (1998) 1.20
Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites. Eur J Surg Oncol (2006) 1.18
Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am J Epidemiol (1996) 1.18
Inverse correlation between Helicobacter pylori infection and inflammatory bowel disease. J Clin Pathol (1996) 1.16
Campylobacter etiology in human gastroenteritis demonstrated by antibodies to acid extract antigen. J Clin Microbiol (1987) 1.16
Effect of erythromycin on the fecal excretion of Campylobacter fetus subspecies jejuni. J Infect Dis (1982) 1.16
Triple therapy of Helicobacter pylori infection in peptic ulcer. A 12-month follow-up study of 93 patients. Scand J Gastroenterol (1992) 1.16
Decreasing prevalence of helicobacter antibodies in Finland, with reference to the decreasing incidence of gastric cancer. Epidemiol Infect (2001) 1.16
Temporal and geographical distribution and overlap of Penner heat-stable serotypes and pulsed-field gel electrophoresis genotypes of Campylobacter jejuni isolates collected from humans and chickens in Finland during a seasonal peak. J Clin Microbiol (2003) 1.14
Evaluation of Pyloriset Screen, a rapid whole-blood diagnostic test for Helicobacter pylori infection. J Clin Microbiol (1998) 1.14
Diagnosis of Helicobacter pylori infection in patients with atrophic gastritis: comparison of histology, 13C-urea breath test, and serology. Scand J Gastroenterol (2000) 1.13
Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age. Epidemiol Infect (2000) 1.10
Explosive school-based measles outbreak: intense exposure may have resulted in high risk, even among revaccinees. Am J Epidemiol (1998) 1.10
Waterborne outbreak of Campylobacter enteritis after outdoors infantry drill in Utti, Finland. Epidemiol Infect (1989) 1.08
Lactobacilli and bacteremia in southern Finland, 1989-1992. Clin Infect Dis (1996) 1.07
Depression of human neutrophil motility by influenza virus in vitro. Scand J Immunol (1977) 1.06
Heterogeneity of Campylobacter pylori as demonstrated by co-agglutination testing with rabbit antibodies. Scand J Gastroenterol Suppl (1988) 1.05
The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella. Epidemiol Infect (2000) 1.05
Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts. Vaccine (1998) 1.05
Contact of lymphocytes with Helicobacter pylori augments natural killer cell activity and induces production of gamma interferon. Infect Immun (1993) 1.05
The seroepidemiology of measles in Western Europe. Epidemiol Infect (2001) 1.04
Progression of coronary artery disease in randomized medical and surgical patients over a 5-year angiographic follow-up. Am J Cardiol (1983) 1.04
Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland. Vaccine (2000) 1.03
Good adhesion properties of probiotics: a potential risk for bacteremia? FEMS Immunol Med Microbiol (2001) 1.03
High frequency of helicobacter negative gastritis in patients with Crohn's disease. Gut (1996) 1.03
Effect of ABO blood group and secretor status on the frequency of Helicobacter pylori antibodies. Scand J Gastroenterol (1990) 1.03
Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy. Gut (2000) 1.02
Biochemical characterization of Campylobacter fetus lipopolysaccharides. Infect Immun (1994) 1.02
Clinical and serological studies in patients with Campylobacter fetus ssp. jejuni infection: II. Serological findings. Infection (1981) 1.02
Antibodies against an acid extract from a single campylobacter strain in hospitalized campylobacter patients. Infection (1983) 1.01
Carditis and arthritis associated with Campylobacter jejuni infection. Acta Med Scand (1980) 1.01
The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia. Aliment Pharmacol Ther (2002) 1.01
Influenza vaccination in 18 developed countries, 1980-1992. Vaccine (1995) 1.00
An outbreak of gastroenteritis from a non-chlorinated community water supply. J Epidemiol Community Health (2004) 1.00
Ribotyping patterns and emergence of metronidazole resistance in paired clinical samples of Helicobacter pylori. J Clin Microbiol (1994) 0.99
Defective chemotaxis in monosomy-7. Nature (1977) 0.99
Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O. Eur J Surg Oncol (2010) 0.99
Allergy gap between Finnish and Russian Karelia on increase. Allergy (2011) 0.99
Ear-lobe crease and coronary atherosclerosis. Lancet (1980) 0.98
Patency of sequential versus single vein grafts in coronary bypass surgery. Thorac Cardiovasc Surg (1982) 0.98
Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up. Vaccine (1995) 0.98
Power Doppler sonography: clinical applications. Eur J Radiol (1998) 0.98
No measles in Finland. Lancet (1997) 0.97
Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Arteriosclerosis (1989) 0.96
Infection with Campylobacter fetus. Scand J Infect Dis (1984) 0.96
Detection of an organ specific protein in the rat thymus. Ann Med Exp Biol Fenn (1966) 0.96
Observations on production, assay and purification of chick embryo interferon. Ann Med Exp Biol Fenn (1965) 0.96
Use of leucocyte migration under agarose to study spontaneous and directed locomotion of leucocytes. Immunology (1978) 0.96
Helicobacter pylori and associated gastroduodenal diseases. Review article. APMIS (1991) 0.96